EU5 Cervical Cancer Market Insights, Epidemiology and Market Forecasts 2016-2023 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Cervical Cancer-Market Insights, Epidemiology and Market Forecast - 2023 - EU5" drug pipelines to their offering.

The therapeutic market size of Cervical Cancer in European (EU5) market is expected to grow at a Compound Annual Growth Rate of 0.019% and reach up to USD 109.8 million by 2023.

The global market size of prophylaxis treatment for Cervical Cancer is expected to grow at a Compound Annual Growth Rate of 0.71% and reach up to USD 2210.9 Million by 2023.

Cervical Cancer needs to be focused more and more because it adversely affects younger women. It is the fourth most common cause of death among women. Cervical Cancer occurs due to the uncontrolled growth of healthy cells in cervix and forms cervical lesions. It spreads to other tissues such as vagina and uterus. Cervical Cancer is caused by inheritance of defects or mutation in genes.

Cervical cancer is also caused due to the infection by the Human Papilloma Virus (HPV) which can infect cells on the surface of the skin and those lining the genitals, anus, mouth and throat, but not the blood or internal organs such as the heart or lungs.

Key Topics Covered:

  1. Report Introduction
  2. Cervical Cancer Disease Overview
  3. Diagnosis of Cervical Cancer
  4. Epidemiology and Patient Population of Cervical Cancer
  5. United Kingdom (UK)
  6. Germany (GE)
  7. Italy (IT)
  8. France (FR)
  9. Spain (SP)
  10. Treatment Landscape
  11. Treatment Algorithm
  12. Treatment by Stages
  13. Cervical Cancer Treatment Regimens
  14. Current Unmet Needs
  15. Cervical Cancer Emerging therapies Market Size
  16. Pipeline Product Analysis
  17. Cervical Cancer Therapeutics Market in Europe
  18. Cervical Cancer Prophylaxis Treatment Global
  19. Market Drivers
  20. Market Barriers
  21. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/zkss6s/cervical

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cervical Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cervical Cancer Drugs